Mackenzie Financial’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Mackenzie Financial’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,950	Closed	-$354K	–	1630
2023 Q2	$354K	Buy	8,950 +530	+6%	+$18.7K	﹤0.01%	1120
2023 Q1	$205K	Buy	+8,420	New	+$184K	﹤0.01%	1337
2016 Q4	–	Sell	-5,100	Closed	-$235K	–	746
2016 Q3	$235K	Sell	5,100 -24,600	-83%	-$1.39M	﹤0.01%	592
2016 Q2	$1.52M	Hold	29,700	–	–	0.01%	504
2016 Q1	$1.25M	Sell	29,700 -1,800	-6%	-$91.7K	0.01%	453
2015 Q4	$2.47M	Sell	31,500 -18,200	-37%	-$1.05M	0.02%	379
2015 Q3	$2.01M	Sell	49,700 -3,400	-6%	-$180K	0.01%	408
2015 Q2	$2.76M	Buy	+53,100	New	+$2.64M	0.02%	380

Mackenzie Financial's ISEE Position: Q3 2023 in Review

Mackenzie Financial sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 8,950 shares — an estimated $354K sold.

Mackenzie Financial first reported a position in ISEE in Q2 2015 and held it in 8 quarters. The position peaked at $2.76M in Q2 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Mackenzie Financial reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Mackenzie Financial sold 8,950 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $354K.
Mackenzie Financial first reported a position in IVERIC bio, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
Mackenzie Financial's IVERIC bio, Inc. Common Stock position peaked at $2.76M in Q2 2015.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Mackenzie Financial's 13F filing for Q3 2023, filed 25 Oct 2023.